ClinicalTrials.gg
CompletedNCT01696006Perfusion CTUpdated Mar 22, 2023

Perfusion CT Registry

An observational study in Coronary Artery Disease, sponsored by Young-Hak Kim, MD, PhD. Completed at 13 sites in Korea, Republic of. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2023-03-22.

Sponsored by Young-Hak Kim, MD, PhD · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
1,059
Ages
20 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 361 studies in Coronary Artery Disease with a site in Korea, Republic of — 81 open to participants now, 103 under way, 2 of them phase 3. Coronary Artery Disease · Korea, Republic of.

Enrollment
77th of 152
1,059 · median 1,113
Started
2013
with 17 others
Observational
153 of 361
40 open now
Registered
101st of 361
by date

Among the 361 studies in Coronary Artery Disease with a site in Korea, Republic of, this one is the 77th largest by enrollment of the 152 observational ones that give a count, is one of 18 that started in 2013, is one of 153 observational ones, and was the 101st registered.

Coronary Artery Disease

4,866 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.

Browse Coronary Artery Disease studies →

Open to participants now

81 of the 361 studies in Coronary Artery Disease with a site in Korea, Republic of are open now. Recruiting first, the newest first:

76 more — sign in →

All 81 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 591 Coronary Artery Disease studies recruiting now, 404 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.

This study: 20 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 361 studies in Coronary Artery Disease with a site in Korea, Republic of, or all of them as a file.
02

Study summary

The purpose of this study is to determine whether coronary perfusion computed tomography is effective in the treatment of coronary artery disease.

03

Conditions studied

  • Coronary Artery Disease

Keywords

  • perfusion computed tomography
  • coronary artery disease
04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

General hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age greater than or equal to 20
  • Patient who has a coronary perfusion computed tomography

Exclusion criteria

Exclusion Criteria:

  • Unwillingness or inability to give
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
1,059 participants (actual)
06

What researchers measure

Primary outcomes

  1. Accuracy of coronary perfusion computed tomography

    Positive predictive value Negative predictive value Sensitivity Specificity

    Time frame: 5year

Secondary outcomes

  1. Relationship between coronary perfusion computed tomography and fraction flow reserve

    Time frame: 5year

  2. Relationship between coronary perfusion computed tomography and SPECT(nuclear imaging)

    Time frame: 5year

  3. occurrence of the event after coronary perfusion computed tomography

    Death Myocardial infarction coronary angiography Revascularization

    Time frame: 5year

07

Study locations

13 sites
  • Asan Medical Center
    Seoul, Songpa-Gu, Korea, Republic of
  • Hallym University Sacred Heart Hospital
    Anyang, Korea, Republic of
  • Soonchunhyang university hospital
    Bucheon, Korea, Republic of
  • Dong-A university hospital
    Busan, Korea, Republic of
  • Kyungpook National University Hospital
    Daegu, Korea, Republic of
  • Chungnam National University Hospital
    Daejeon, Korea, Republic of
  • The Catholic University of Korea, Daejeon ST. Mary's Hospital
    Daejeon, Korea, Republic of
  • Chonnam National University Hospital
    Gwangju, Korea, Republic of
  • ChonBuk National University Hospital
    Jeonju, Korea, Republic of
  • Inje university Pusan Paik hospital
    Pusan, Korea, Republic of
  • Pusan National University Hospital
    Pusan, Korea, Republic of
  • Pusan National University Yangsan Hospital
    Pusan, Korea, Republic of
  • Ulsan University Hospital
    Ulsan, Korea, Republic of
08

References and documents

Publications

  • Kwon O, Hwang HJ, Koo HJ, Yang DH, Kang HJ, Kim JA, Moon DH, Kim HS, Kang JW, Kim YH. Ischemic burden assessment of myocardial perfusion CT, compared with SPECT using semi-quantitative and quantitative approaches. Int J Cardiol. 2019 Mar 1;278:287-294. doi: 10.1016/j.ijcard.2018.12.046. Epub 2018 Dec 17. PubMed 30587418 ↗
  • Kang SJ, Kweon J, Yang DH, Lee JG, Jung J, Kim N, Mintz GS, Kang JW, Lim TH, Park SW, Kim YH. Mathematically Derived Criteria for Detecting Functionally Significant Stenoses Using Coronary Computed Tomographic Angiography-Based Myocardial Segmentation and Intravascular Ultrasound-Measured Minimal Lumen Area. Am J Cardiol. 2016 Jul 15;118(2):170-6. doi: 10.1016/j.amjcard.2016.04.049. Epub 2016 May 5. PubMed 27236253 ↗
  • Kang SJ, Yang DH, Kweon J, Kim YH, Lee JG, Jung J, Kim N, Mintz GS, Kang JW, Lim TH, Park SW. Better Diagnosis of Functionally Significant Intermediate Sized Narrowings Using Intravascular Ultrasound-Minimal Lumen Area and Coronary Computed Tomographic Angiography-Based Myocardial Segmentation. Am J Cardiol. 2016 Apr 15;117(8):1282-8. doi: 10.1016/j.amjcard.2016.01.022. Epub 2016 Jan 28. PubMed 26892449 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2013 to primary completion in Nov 2020, 84 months.

Of 637 non-industry observational studies under Coronary Artery Disease, half reached primary completion within 48 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 122. This study's 84 months is above that.

Counting every sponsor, half of 762 studies reached it within 41 months; a quarter within 21 and three quarters within 87.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 26, 2012
First posted
Sep 28, 2012
StartActual
Nov 22, 2013
Primary completionActual
Nov 25, 2020
CompletionActual
Jan 14, 2021
Last update
Mar 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01696006
Lead sponsor
Young-Hak Kim, MD, PhD
Responsible party
Young-Hak Kim, MD, PhD (Young-Hak Kim, MD, PhD, Asan Medical Center) — Sponsor-investigator
First posted
Sep 28, 2012
Start date
Nov 22, 2013
Primary completion
Nov 25, 2020
Completion
Jan 14, 2021
Last update
Mar 22, 2023
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion